General Proximity
21 employees
Biotech/Pharma
Seed · $16.0M
Open positions (9)
Company details
Team Size21
IndustryBiotech/Pharma
Funding
Total raised
$16.0M
Last stage
Seed
Investors
age1
Total raised
$16.0M
Last stage
Seed
Investors
Armand B. Cognetta III
PhD in Chemical Biology from the Scripps Research Institute under Dr. Benjamin Cravatt. Co-authored 19 scientific publications in Cell, Nature, and Science. Early employee at Flagship Pioneering's Inzen Therapeutics. Went through Y Combinator as a solo founder to launch General Proximity.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.